Skip to main content
SpringerLink
Log in
Book cover

New Concepts in the Pathogenesis of NIDDM pp 89–100Cite as

The Diabetogenes Concept of NIDDM

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 334))

Abstract

It is not very often that I am asked to lecture about the pathogenesis of NIDDM, and I even imagine that many of my distinguished colleagues assume that I don’t have an original opinion on the matter. I felt therefore very privileged to be asked to present my views on NIDDM in this Symposium honoring Professor Rolf Luft.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected References

  1. D.J. Porte, and J.D. Bagdade, Human insulin secretion: an integrated approach, Ann. Rev. Med. 21: 219 (1970).

    Article  PubMed  CAS  Google Scholar 

  2. J.R. Olefsky, and O.G. Kolterman, Mechanism of insulin resistance in obesity and noninsulin-dependent (type II) diabetes, Am. J. Med. 70:151 (1981).

    Article  PubMed  CAS  Google Scholar 

  3. C.R. Kahn, Insulin resistance: a common feature of diabetes mellitus, N. Engl. J. Med. 315:252 (1986).

    Article  PubMed  CAS  Google Scholar 

  4. S. Efendic, R. Luft, and A. Wajngot, Aspects of the pathogenesis of type 2 diabetes, Endocrine Reviews. 5:395 (1984).

    Article  PubMed  CAS  Google Scholar 

  5. R.A. De Fronzo, E. Ferrannini, V. Koivisto, New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus, Am. J. Med. 74:1A, 52 (1983).

    Google Scholar 

  6. L.J. Mandarino, and J.E. Gerich, Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at postreceptor site in hepatic as well as extrahepatic tissues, Diabetes Care 7:suppl.1, 89 (1984).

    PubMed  Google Scholar 

  7. R.A. De Fronzo, R.C. Bonadonna and E. Ferrannini, Pathogenesis of NIDDM: a balanced overview, Diabetes Care 15:318 (1992).

    Article  Google Scholar 

  8. R.A. De Fronzo, Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview, Diabetologia 35:389 (1992).

    Article  Google Scholar 

  9. D. Porte, Jr., Beta cells in type II diabetes mellitus, Diabetes 40:166 (1990).

    Article  Google Scholar 

  10. S. Dinneen, J. Gerich and R. Rizza, Carbohydrate metabolism in non-insulin-dependent diabetes mellitus, N. Engl. J. Med. 327:707 (1992).

    Article  PubMed  CAS  Google Scholar 

  11. C.R. Kahn, D.M. Neville, Jr., and J. Roth, Insulin receptor interaction in the obese-hyperglycemic mouse: a model of insulin resistance, J. Biol. Chem. 248:244 (1973).

    PubMed  CAS  Google Scholar 

  12. A.H. Soll, C.R. Kahn, and D.M. Neville, Jr., Insulin binding to liver plasma membranes in the obese hyperglycemic (ob/ob) mouse. Demonstration of a decreased number of functionally normal receptors, J. Biol. Chem. 250:4702 (1975).

    PubMed  CAS  Google Scholar 

  13. A.H. Soll, C.R. Kahn, D.M. Neville, Jr., and J. Roth, Insulin receptor deficiency in genetic and acquired obesity. J. Clin. Invest. 56:769 (1975).

    Article  CAS  Google Scholar 

  14. J.M. Olefsky, Decreased insulin binding to adipocytes and circulating monocytes from obese patients, J. Clin. Invest. 57:1165 (1976).

    Article  PubMed  CAS  Google Scholar 

  15. R.S. Bar, P. Gorden, J. Roth, C.R. Kahn, and P. De Meyts, Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients. Effects of starvation, refeeding and dieting, J. Clin. Invest. 58:1123 (1976).

    Article  PubMed  CAS  Google Scholar 

  16. J.R. Gavin, III, J. Roth, D.M. Neville, Jr, P. De Meyts, and D.N. Buell, Insulin-dependent regulation of insulin receptor concentrations. A direct demonstration in cell culture, Proc. Natl. Acad. Sci. U.S.A. 71:74 (1974).

    Article  Google Scholar 

  17. J.L. Carpentier, The cell biology of the insulin receptor, Diabetologia 32:627 (1989).

    Article  PubMed  CAS  Google Scholar 

  18. J.M. Olefsky, and G.M. Reaven, Insulin binding in diabetes, relationships with plasma insulin levels and insulin sensitivity, Diabetes 26:680 (1977).

    PubMed  CAS  Google Scholar 

  19. H. Beck-Nielsen, The pathogenic role of an insulin receptor defect in diabetes mellitus of obese, Diabetes 27:1175 (1978).

    PubMed  CAS  Google Scholar 

  20. C.R. Kahn, Pathophysiology of Diabetes Mellitus: an Overview, in Joslin Diabetes Mellitus, Twelth Edition, A. Marble, L.P. Krall, R.F. Bradley, A.R. Christlieb, J.S. Soeldner, eds., Lea and Fibiger, Philadelphia, p. 43 (1985).

    Google Scholar 

  21. J.D. Rawn, Biochemistry, Neil Patterson Publishers, Burlington, North Carolina, p. 398 (1989).

    Google Scholar 

  22. P. De Meyts, Insulin receptors and diabetes, Medicographia vol. 3, 3:8 (1983).

    Google Scholar 

  23. J.M. Olefsky, and G.M. Reaven, Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients, Am J. Med., 60:89 (1976).

    Article  PubMed  CAS  Google Scholar 

  24. M.N. Feinglos, and H.E. Lebovitz, Sulphonylureas increase the number of insulin receptors, Nature (London) 276:184 (1978).

    Article  CAS  Google Scholar 

  25. J.M. Prince, and J.M. Olefsky, Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors, J. Clin. Invest. 66:608 (1980).

    Article  PubMed  CAS  Google Scholar 

  26. E. Marchand, F. Grigorescu, M. Buysschaert, P. De Meyts, J.M. Ketelslegers, H. Brems, M.C. Nathan, and A.E. Lambert, The hypoglycemie effect of a sulfonylurea (gliclazide) in moderate type II diabetes is not accompanied by changes in insulin action and insulin binding to erythrocytes, Molecular Physiol. 4:83 (1983).

    CAS  Google Scholar 

  27. P. De Meyts, F. Grigorescu, and B. Lambert, The role of insulin receptors in the hypoglycemie effect of sulfonylureas: the status of 1982, in Rationale for Sulfonylurea Therapy, E.F. Pfeiffer, ed. Excerpta Medica, Amsterdam, p. 71 (1983).

    Google Scholar 

  28. R. Vigneri, V. Pezzino, K.Y. Wong, and I.D. Goldfine, Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding to its receptors in target cells, J. Clin. Endo. Metab. 54:95 (1982).

    Article  CAS  Google Scholar 

  29. J. Dolais-Kitabgi, F. Alengrin, and P. Freychet, Sulfonylureas in vitro do not alter insulin binding and effects on aminoacid transport in hepatocytes, Diabetologia 24:441 (1983).

    Article  PubMed  CAS  Google Scholar 

  30. B.L. Nyomba, V.M. Ossowski, C. Bogardus, and D.M. Mott, Insulin-sensitive tyrosine kinase relationship with in vivo insulin action on humans, Am. J. Physiol. 258:E964 (1990).

    PubMed  CAS  Google Scholar 

  31. R.S. Yalow, and S.A. Berson, Immunoassay of endogenous plasma insulin in man, J. Clin. Invest. 39:1157 (1960).

    Article  PubMed  CAS  Google Scholar 

  32. R. Temple, P.M.S. Clarck, and C.N. Hales, Measurement of insulin secretion in type 2 diabetes: problems and pitfalls, Diabetic Medicine 9:503 (1992).

    Article  PubMed  CAS  Google Scholar 

  33. S. Taylor, Molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin receptor gene, Diabetes 41:1473 (1992).

    Article  PubMed  CAS  Google Scholar 

  34. H.S. Tager, Insulin gene mutations and abnormal products of the human insulin gene, in Hormone Resistance and Other Endocrine Paradoxes, M.P. Cohen and P.P. Foà, eds., Springer-Verlag, New York, p. 35 (1987).

    Chapter  Google Scholar 

  35. L. Mosthaf, B. Vogt, H. Häring, and A. Ullrich, Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients, Proc. Natl. Acad. Sci. U.S.A. 88:4728 (1991).

    Article  PubMed  CAS  Google Scholar 

  36. G. Sesti, M.A. Marini, A.N. Tullio, A. Motemurro, P. Borboni, A. Fusco, D. Accili, and R. Lauro, Altered expression of the two naturally occuring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients, Biochem. Biophys. Res. Commun., 181:1419 (1991).

    Article  PubMed  CAS  Google Scholar 

  37. L. Mosthaf, J. Erikson, H.U. Häring, L. Groop, E. Widen, and A. Ullrich, Insulin receptor isotype expression correlates with risk of non-insulin-dependent diabetes, Proc. Natl. Acad. Sci. U.S.A. 90: 2633 (1993).

    Article  PubMed  CAS  Google Scholar 

  38. H. Benecke, J.S. Flier, and D.E. Moller, Alternatively spliced variants of the insulin receptor protein. Expression in normal and diabetic human tissues, J. Clin. Invest. 89:2066 (1992).

    Article  PubMed  CAS  Google Scholar 

  39. T. Hansen, C. Bjorbæk, H. Vestergaard, J.F. Bak, and O. Pedersen, Alternatively spliced variants of the insulin receptor and its functional correlates in muscle from patients with type 2 diabetes and normal subjects, Diabetologia 35suppl. 1:A 76, abstract 290 (1992).

    Google Scholar 

  40. S. Efendic, V. Grill, R. Luft and A. Wajngot, Low insulin response: a marker of prediabetes. Adv. Exp. Med. Biol. 246:167 (1988).

    Article  PubMed  CAS  Google Scholar 

  41. E. Cerasi, R. Luft, and S. Efendic, Decreased sensitivity of the pancreatic beta cells to glucose in pre-diabetic and diabetic subjects, Diabetes 21:224 (1972).

    PubMed  CAS  Google Scholar 

  42. H. Yoneda, H. Ikegami, Y. Yamamoto, E. Yamato, T. Cha, Y. Kawaguchi, Y. Tahara and T. Ogihara, Analysis of early-phase insulin response in nonobese subjects with mild glucose intolerance, Diabetes Care 15:1517 (1992).

    Article  PubMed  CAS  Google Scholar 

  43. M.A. Permutt, K.C. Chu and Y. Tanizawa, Glucokinase and NIDDM. A candidate gene that paid off, Diabetes 41:1367 (1992).

    Article  PubMed  CAS  Google Scholar 

  44. K. Phipps, D.J.P. Barker, C.N. Hales, C.H.D. Fall, C. Osmond and P.M.S. Clark, Fetal growth and impaired glucose tolerance in men and women, Diabetologia 36:225 (1993).

    Article  PubMed  CAS  Google Scholar 

  45. R.A. De Fronzo, The triumvirate: beta cell, muscle, liver: a collusion responsible for NIDDM, Diabetes 37: 667 (1988).

    CAS  Google Scholar 

  46. D.K. Granner, and R.M. O’Brien, Molecular physiology and genetics of NIDDM. Importance of metabolic staging, Diabetes Care 15:369 (1992).

    Article  PubMed  CAS  Google Scholar 

  47. A.A. Rossini, J.P. Mordes, and E.S. Handler, Speculations on etiology of diabetes mellitus. Tumbler hypothesis, Diabetes 37:257 (1988).

    Article  PubMed  CAS  Google Scholar 

  48. J. Nerup, T. Mandrup-Poulsen, and J. Mølvig, The HLA-IDDM association: implications for etiology and pathogenesis of IDDM, Diabetes/Metabolism Reviews 3:779 (1987).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hagedorn Research Institute, Niels Steensens Vej 6, DK 2820, Gentofte, Denmark

    Pierre De Meyts

Authors
  1. Pierre De Meyts
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Karolinska Hospital, Stockholm, Sweden

    Claes Göran Östenson  & Suad Efendić  & 

  2. University of Toronto, Toronto, Ontario, Canada

    Mladen Vranic

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

De Meyts, P. (1993). The Diabetogenes Concept of NIDDM. In: Östenson, C.G., Efendić, S., Vranic, M. (eds) New Concepts in the Pathogenesis of NIDDM. Advances in Experimental Medicine and Biology, vol 334. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2910-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2910-1_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6262-3

  • Online ISBN: 978-1-4615-2910-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation